2008 Annual Meeting | Patient Safety Colloquium: Essential Patient Safety for the Neurologist

2008 Annual Meeting | Patient Safety Colloquium: Essential Patient Safety for the Neurologist - Does Your Practice Measure Up?

Date Sunday 04/13/08

Time 09:00 AM - 12:00 PM Add To Calendar

Session Format This program will be presented both in-person and online

On Demand This program is not expected to be available in the meeting's On Demand product.

Event Type Colloquium

Director(s) Michael J. Kaminski, MD, FAAN

Topic(s)

Learning Objectives Participants should be able to demonstrate awareness of the key role of measurement in neurology patient safety; know key essential safety measures to be monitored at each patient encounter; understand ongoing patient safety activities in an innovative residency training program; be aware of monitoring safety issues in hospital stroke patients; understand the current and future role of third-party payers in evaluating patient safety; and be aware of updated online AAN tools available to implement patient safety strategies now.

CME Available No CME available

Core Competencies Patient Care & Procedural Skills, Interpersonal and Communication Skills, Professionalism, Medical Knowledge, Practice-based Learning and Improvement, Systems-based Practice

Program Level Introductory

Recommended Audience Practitioner, Fellow, Resident, Nurse, Other

Event Timeline
09:00 AM - 09:30 AM		Measurement: An Essential Step in Patient Safety Daniel M. Feinberg, MD, FAAN
09:30 AM - 09:55 AM		The Essential Patient Safety Checklist Michael J. Kaminski, MD, FAAN
09:55 AM - 10:25 AM		Measure Patient Safety in Residency Training Eric M. McDade, DO, Brian C. Salter, MD
10:25 AM - 10:40 AM		Break
10:40 AM - 11:05 AM		Patient Safety in Hospital Stroke Care Robert G. Holloway, MD, MPH, FAAN
11:05 AM - 11:30 AM		The Payer Perspective on Neurology Patient Safety David A. Stumpf, MD, PhD, FAAN
11:30 AM - 12:00 PM		Finding the Tools to Help You Measure Patient Safety in Your Practice Robert M. Kropp, MD, FAAN

Faculty Disclosures
Robert G. Holloway, MD, MPH, FAAN	Dr. Holloway has nothing to disclose.
Michael J. Kaminski, MD, FAAN	No disclosure on file
Robert M. Kropp, MD, FAAN	Dr. Kropp has stock in RxLive, LLC. Dr. Kropp has a non-compensated relationship as a Investor with RxLive that is relevant to AAN interests or activities.
Daniel M. Feinberg, MD, FAAN	Dr. Feinberg has received personal compensation in the range of $5,000-$9,999 for serving as an Expert Witness for Hospitals.
Brian C. Salter, MD	No disclosure on file
David A. Stumpf, MD, PhD, FAAN	No disclosure on file
Eric M. McDade, DO	Dr. McDade has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Sanofi. Dr. McDade has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Merck. Dr. McDade has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Alector. Dr. McDade has received personal compensation in the range of $5,000-$9,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Alzamend. Dr. McDade has received personal compensation in the range of $5,000-$9,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Fondation Alzheimer. Dr. McDade has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Alnylam. Dr. McDade has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Merck. Dr. McDade has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Ionis. The institution of Dr. McDade has received research support from NIA. The institution of Dr. McDade has received research support from Eli Lilly. The institution of Dr. McDade has received research support from Hoffman-La Roche. The institution of Dr. McDade has received research support from Eisai. The institution of Dr. McDade has received research support from Eisai. Dr. McDade has received intellectual property interests from a discovery or technology relating to health care. Dr. McDade has received personal compensation in the range of $500-$4,999 for serving as a Advisory Board Member with Fondation Alzheimer.

��ɫ��

��ɫ��